11/13
07:17 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/13
07:17 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/13
05:18 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/13
05:18 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
11/12
08:33 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $130.00 price target on the stock.
Medium
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $130.00 price target on the stock.
11/12
07:39 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
11/12
07:39 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
10/4
12:06 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
10/4
12:06 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/20
01:21 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/16
12:11 pm
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
9/16
11:23 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/9
11:19 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/6
11:04 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
9/6
10:11 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/5
08:07 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $130.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $130.00 price target on the stock.
9/5
08:06 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
9/5
06:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/5
06:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/3
08:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/3
08:45 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
9/3
08:03 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $140.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $140.00 price target on the stock.